Karsinoma Hepatoseluer (KHS) 
Radiotherapy is among one of the modalities in the treatment of hepatocellular carcinoma. Its primary usage was for palliative treatment in unresectable cases, but it can also be used as a neodajuvant treatment before liver resection. Previously , there was no documented report on the use of radiotherapy in hepatocellular carcinoma at RS Dr. Ciptomangunkusumo. We report a case of preoperative radiotherapy for icteric type hepatocellular carcinoma in our hospital in which the result was satisfactory for further liver resection.
CASE ILLUSTRATION
Male, 66 years old, with dyspepsia and jaundice but no history of previous liver diseases. He had icteric eye and skin, hepatomegaly and no sign of mass in the abdomen. The total and direct bilirubin level at admission was 15.8 mg/dl and 11.6 mg/dl respectively. The Albumin level was 3,3 g/dl, with AFP 8 ng/ml and normal Prothrombin time (14; control 13,8) with ChildPugh B classification.
CT scan uncovered a low density mass at segment 8 of the liver measuring 81 x 119 mm that compressed the biliary radix and hepatic artery with no associated ascites nor lymph node enlargement ( Fig 1A) . No metastasis sign was found in the plain thorax photo. And the cytology of the liver biopsy confirmed the diagnosis of Hepatocellular Carcinoma.
Figure 1. CT scan Pre Radiation (A) and Post Radiation (B)
The result of Trans Arterial Chemotherapy with Lipiodol and Adryamicin was unsatisfactory. We found compression of biliary radix due to liver mass at segment 4,5 and 8, with mild dilatation of the intrahepatic biliary ducts on MRCP. Furthermore, ERCP confirmed the existence of Common Bile Duct obstruction (Fig 2) . This patient undergone Three Dimensional Conformal Radiotherapy (3D-CRT) using Linear Accelerator with the total dose of 30 Gy (2 Gy/fraction). After Radiotherapy, CT scan showed hyperdens mass at the right lobe of the liver, measuring 103 x 147 mm with no dilatation of biliary system ( Fig 1B) 
Figure 2. ERCP pre radiation
The general condition after radiotherapy was good, with marked decreased of jaundice and dyspepsia. The total bilirubin level and albumin was 7.85 mg/dl and 3 g/dl respectively (Fig 3) . On follow up, there were no major complains and this patients was planned to undergo liver resection. 
DISCUSSION
Hepacocellular carcinoma is one of the most common malignancies worldwide, with an increasing incidence. In Indonesia, HCC is commonly found in men, between 50-60 years old. The treatment of this disease remains one of the most challenging problems. Despite advances in diagnosis and treatment, the 5-year survival rate is only 50 -70 %. 1, 2 The clinical manifestations of HCC are varies among patients. Most of them came with a history of right upper quadrant pain, followed with dyspepsia, and loss of body weight. 1, 3, 4 Our patient came with dyspepsia, RUQ pain and jaundice. This symptoms showed a disturbance in the liver without specifically pointed to HCC.
Based on the underlying pathophysiology, jaundice in HCC can be classified into two types: hepatocellular type and icteric type. 3 The jaundice in icteric type is caused by obstruction of the bile ducts by the tumour. 3, 4 Initially, the icteric type of HCC was attributed to one of the following mechanisms: (i) a tumour may erode into a branch of the biliary tree and grow distally until it fills up the entire extrahepatic biliary tree to form a biliary tumour thrombus in the extrahepatic bile ducts; (ii) a necrotic free-floating fragment of tumour may separate from the biliary tumour thrombus and migrate distally to obstruct the common bile duct. Fragments of tumour in the bile duct, as described by Edmonson and Steiner, are usually fragile, fleshy and grey-white and have the appearance of chicken fat;4 and (iii) sometimes, bleeding from the biliary tumour thrombus may partially or completely fill up thebiliary tree with blood clots that obstruct the biliary system. 3, 4 The reported incidence of icteric type of HCC varies from 0.5 to 13% of all patients with HCC. 3 With the increasing recognition of the icteric type of HCC, a classification with therapeutic implication is needed. Lau et al. classified icteric type of HCC into the extrahepatic and the intrahepatic types (Fig 4) . This classification has important therapeutic and prognostic value as patients with extrahepatic biliary obstruction secondary to HCC have a higher curative resection rate, which results in a significantly improved survival rate compared with those patients with intrahepatic biliary obstruction. It is important to determine the underlying cause of jaundice after establishing the diagnosis of HCC either by using Ultrasonography, CT Scan, ERCP or MRCP. The large mass in the liver with evidence of marked obstruction in the biliary system confirmed the diagnosis.
3, 4
The first aspect of management is to stabilize the patient, drain the obstructed biliary tree and/or to control the bleeding from the tumour. The second aspect of management is to assess the resectability of the tumour with appropriate investigations. Determination of resectability depends on tumor stage, hepatic functional reserve and local standards of practice. The addition of effective adjuvant or neoadjuvant therapy (regional or systemic) would greatly affect survival after resection if recurrence rates could be decreased. 3 The use of radiotherapy as a palliative or neoadjuvant treatment is mainly based on the local effect of radiation at the tumor site, without harming the healthy liver tissue. 2 This can be adequately achieved by using three dimensional conformal radiotherapy (3D-CRT) in which we can adjust the dose of radiation to different location of the liver. 5 Other method of Radiation Therapy is Fractionated Stereotactic RT which is a relatively safe and effective local treatment for small primary HCC and is also useful for patients who are medically inoperable or who refuse surgery. 6 The indication for 3DCRT including to eliminate the tumor thrombi at the portal vein, obstructive jaundice, failure of Transarterial Chemotherapy (TACE), or in combination with surgical resection and other treatment modalities. 7 There was a significantly improved survival rate in patients undergone TACE and Radiation Therapy than in TACE alone. Therefore, RT in addition to TACE is strongly recommended for patients with an unresectable HCC. 8, 9, 10 In this case, we used 3D-CRT with a total dose of 30 Gy according to Tokuuye et al 11 (Table 1) . After radiation, the liver function normalize gradually, which was shown by the decreased of bilirubin level to 7,85 mg/dl, compared to the initial (15,8 mg/dl) and when we started the radiation (19,64 mg/dl). 
CONCLUSION
Paliation of symptoms can be achieved using radiotherapy in certain types of HCC and thus providing a good condition for further resection.
